The historical rank and industry rank for Fortis Malar Hospitals's ROE % or its related term are showing as below:
BOM:523696'
s ROE % Range Over the Past 10 Years
Min: -21.46 Med: 1.27 Max: 52.2
Current: 12.55
During the past 13 years, Fortis Malar Hospitals's highest ROE % was 52.20%. The lowest was -21.46%. And the median was 1.27%.
BOM:523696's ROE % is ranked better than 70.13% of 626
companies
in the Healthcare Providers & Services industry
Industry Median: 5.805
vs BOM:523696: 12.55
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Fortis Malar Hospitals's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fortis Malar Hospitals ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fortis Malar Hospitals's ROE % distribution charts can be found below:
* The bar in red indicates where Fortis Malar Hospitals's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Fortis Malar Hospitals (BOM:523696) has a ROE % of -0.52% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Fortis Malar Hospitals and its competitors. According to the industry distribution chart, Fortis Malar Hospitals ranks #187 out of 626 companies in the Healthcare Providers & Services industry, placing it in the top 29.9%.
Is Fortis Malar Hospitals' ROE % too high?
Fortis Malar Hospitals' current ROE % is -0.52%. Based on the distribution chart, Fortis Malar Hospitals ranks #187 out of 626 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fortis Malar Hospitals has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fortis Malar Hospitals' ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fortis Malar Hospitals ranks #187 out of 626 companies for ROE %. This puts Fortis Malar Hospitals in the upper half of its industry. The industry median ROE % is 5.81. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.81, based on 626 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Fortis Malar Hospitals and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fortis Malar Hospitals's current ROE % is -0.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortis Malar Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Fortis Malar Hospitals (BOM:523696) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹0.03, compared to a current price of ₹52.38 — trading 174500% above its estimated fair value. The current ROE % is -0.52%. Fortis Malar Hospitals' overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Fortis Malar Hospitals (BOM:523696), the current ROE % is -0.52% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fortis Malar Hospitals (BOM:523696) Overvalued in 2026?
Based on GuruFocus' analysis, Fortis Malar Hospitals stock appears to be overvalued.
The current stock price of ₹52.38 is trading 174500% above its estimated GF Value™ of ₹0.03.
GuruFocus considers Fortis Malar Hospitals to be Significantly Overvalued.
Key valuation signals for BOM:523696:
ROE %: -0.52%
GF Value™: ₹0.03 vs. price of ₹52.38 (174500% above fair value)
No single metric tells the full story. See the BOM:523696 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fortis Malar Hospitals Ltd is an India-based company engaged in the provision of healthcare services. It focuses on providing medical care in the areas of cardiology and cardiac surgery, neurosurgery, gynecology, orthopedics, gastroenterology, neurology, pediatrics, diabetes, nephrology, and internal medicine. The company provides healthcare services in various branches of medicine such as general surgery, general medicine, pediatrics, neurology, cardiology, ophthalmology, radiology, pathology, gastroenterology, urology, thoracic surgery, plastic surgery, and other allied specialties. It operates in one business, namely, in the health care services.
32GF Score
Get the complete analysis for BOM:523696
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:523696 has been successfully added to your 
